ArticleInternational urology and nephrology2026

Integrated bioinformatics analysis and clinical validation identifies TNFSF14 and CD40 as novel biomarkers for chronic kidney disease progression and tubulointerstitial injury.

Xiameng Gu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.